Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Randomized Comparison Clinical Trial of Target Activated CIK for Advanced Lung Cancer

NCT03501056 is registered in ClinicalTrials.gov with Fuda Cancer Hospital, Guangzhou as lead sponsor.

NCT NCT03501056
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03501056 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Randomized Comparison Clinical Trial of Target Activated CIK for Advanced Lung Cancer
Lead sponsor
Fuda Cancer Hospital, Guangzhou
Phase
Phase 2
Overall status
Withdrawn
Start date
March 27, 2018
Completion date
July 27, 2020
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced lung cancer